Boehringer Ingelheim, IBM partner to expedite antibody discovery
Under the partnership, Boehringer will leverage an AI model developed by IBM, initially pre-trained and subsequently fine-tuned using…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Nov 23
Under the partnership, Boehringer will leverage an AI model developed by IBM, initially pre-trained and subsequently fine-tuned using…
28 Nov 23
CEO Frederic Revah discusses how Artificial Intelligence is creating next-generation gene therapy vectors and reducing bioproduction costs in…
27 Nov 23
Nefecon is a patented, oral delayed-release formulation of budesonide, a corticosteroid with potent glucocorticoid activity and weak mineralocorticoid…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
27 Nov 23
The therapeutic vaccine candidate is currently slated to enter into a Phase 1b trial following the completion of…
Patient CarePharmaceuticals and MedicinesPartnerships and Licensing Agreements
27 Nov 23
The NMPA has also granted Priority Review designation to GFH925 for treating patients with advanced non-small cell lung…
27 Nov 23
With adherence to stringent international regulatory guidelines, the new facility at Pithampur marks a significant leap in manufacturing…
24 Nov 23
The investment is expected to boost the manufacturing site's capability and improve Novo Nordisk's capacity to satisfy future…
24 Nov 23
Designed to provide protection for infants throughout an entire RSV season, AK0610 has been genetically engineered from a…
24 Nov 23
EP0031 is a potential next-generation selective RET inhibitor with a wide activity against general RET fusions and mutations,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
24 Nov 23
Bayer’s new production facility is grounded in a new platform technology that encompasses a broad spectrum of chemically…